Sexually transmitted infections in the Netherlands in 2018

Autor: Slurink, IAL, van Aar, F, Op de Coul, ELM, Heijne, JCM, van Wees, DA, Hoenderboom, BM, Visser, M, den Daas, C, Woestenberg, PJ, Gotz, HM, Nielen, M, van Sighem, AI, van Benthem, BHB

In 2018 hebben vrijwel evenveel mensen zich bij een Centrum voor Seksuele Gezondheid (CSG) laten testen op seksueel overdraagbare aandoeningen (soa) als in 2017. Het percentage dat daadwerkelijk een soa had bleef gelijk. Chlamydia bleef de meest voor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::ae451bf3f4acd87acfc705fa6ea9c703
http://hdl.handle.net/10029/623123

Sexually transmitted infections in the Netherlands in 2015

Autor: van den Broek IVF, van Aar F, van Oeffelen AAM, Woestenberg PJ, Heijne JCM, den Daas C, Hofstraat SHI, Hoenderboom BM, van Wees D, van Sighem AI, Nielen MMJ, van Benthem BHB, SOA, I&V

Het aantal mensen dat zich bij een Centrum Seksuele Gezondheid (CSG) heeft laten testen op een seksueel overdraagbare aandoening (soa) is, na een jarenlange stijging, in 2015 gedaald. De daling hangt samen met een sterkere focus op de doelgroep van d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::4e4a8991f089617b6fb5bd9f55e6bb9b
http://hdl.handle.net/10029/614880

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity : Evidence for Cross-Protection Against Oncogenic Types among Dutch STI Clinic Visitors

Autor: Woestenberg, PJ, King, AJ, van Benthem, BH, Donken, R, Leussink, S, van der Klis, FRM, de Melker, HE, van der Sande, M A J, Hoebe, CJ, Bogaards, JA, Adema, D, Buist-Arkema, R, Beerens, A, Luijt, D, Meijer, S, Schirm, J, Peeters, M, Rossen, JWA (John), Verbakel, H, Esch, PV, Verweij, J, Baltissen - van der Eijk, Annemiek, Huisman, RC, Kerkhof, C, Korff, MH, Schutten, M (Martin), Velzing, J, Verduyn-Lunel, F, Lakbiach, S, Rosmalen, PV, Schuurman, R (Rob), Abma, D, Adams, K, Bruisten, S, Linde, I, Oostvogel, P, Touwen, C, Vermeulen, W, Brink, A, Nelissen, J, Wolffs, P, Duijvendijk, N, Schneeberger, P, Poppel, MDV, Melchers, W, Poort, Y, Hooghiemstra, M, Huisman, H, Weel, J, Bosma, F, Geeraedts, F, Polman, I, Van Goor, P, Wolfhagen, M, De Mooij, C, Koolwijk, EV, Peters, M, Swanink, C, Tiemessen, R, Zwet, TV, Janssen, J, Pelsers, M, Waal, W, Aalfs, G, Kiewiet, J, Sanders, P, Buel-Bruins, HV, Bokhoven-Rombouts, CV, Cornelissen, P, Kersten, M, Ruitenbeek, CV, Molenaar, I, van Doorn, E, Masthoff, L, Pannekoek, E, Sigurdsson, V, Bugter, M, Götz, H, Linden, M, Mattijssen, M, Stam, J, Swaders, E, Groot, FD, Postma, F, Brouwers, E, Niekamp, A, Smit, M, Botraby, A, Bukasa, D, Haan, CD, Vliet, P, Taconis, T, Graas, MD, Hondelink, I, Kampman, C, Gelissen-Hansen, A, Koning, ID, Kruchten, HV, Pas, MVD, Fennema, H, Heijman, T, Hogewoning, A, Leeuwen, AV, Rooijen, MV, Neienhuijsen, F, Pelgrim, M

Publikováno v: Journal of Infectious Diseases, 217(2), 213-222. Oxford University Press
Woestenberg, P J, King, A J, van Benthem, B H B, Donken, R, Leussink, S, van der Klis, F R M, de Melker, H E, van der Sande, M A B, Hoebe, C J P A, Bogaards, J A & Medical Microbiological Laboratories, and the Public Health Services 2018, ' Bivalent vaccine effectiveness against type-specific HPV positivity : evidence for cross-protection against oncogenic types among Dutch STI clinic visitors ', Journal of Infectious Diseases, vol. 217, no. 2, pp. 213-222 . https://doi.org/10.1093/infdis/jix582
The Journal of Infectious Diseases
The Journal of Infectious Diseases, 217(2), 213-222. Oxford University Press
Journal of Infectious Diseases, 217(2), 213. Oxford University Press

In this cross-sectional study among vaccine-eligible female sexually transmitted infection clinic visitors, high vaccine effectiveness of the bivalent vaccine against the vaccine types HPV-16/18 was demonstrated and significant cross-protection again

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cf17240357b3738981f34e17f396cd1
https://hdl.handle.net/1874/363631

A comparison of infants' birth defects self-reported by mothers with data provided by general practitioners: Data from the Dutch Pregnancy Drug Register.

Autor: Maas VYF; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., Ederveen EGT; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Rijt-Weetink YRJ; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., Woestenberg PJ; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., Bergman JEH; Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Conijn M; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.

Publikováno v: Birth defects research [Birth Defects Res] 2024 Jan; Vol. 116 (1), pp. e2276. Date of Electronic Publication: 2023 Nov 23.

Maternal first trimester COVID-19 vaccination and risk of major non-genetic congenital anomalies.

Autor: Woestenberg PJ; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands., de Feijter M; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands., Bergman JEH; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Lutke LR; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Passier AJLM; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands., Kant AC; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands.; Department of Clinical Pharmacology and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.

Publikováno v: Birth defects research [Birth Defects Res] 2023 Nov 01; Vol. 115 (18), pp. 1746-1757. Date of Electronic Publication: 2023 Sep 22.